Cargando…

OTHR-11. TUMOR RELATED IMPAIRMENTS OF NEUROCOGNITIVE FUNCTIONS IN PATIENTS WITH BRAIN METASTASES

OBJECTIVE: To study whether the neurocognitive functions were affected by brain metastases in patients, and what are the potential risk factors. METHODS: A total of 172 patients with brain metastases were retrospectively analyzed. Prior to radiotherapy of brain metastases, the neurocognitive functio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhen, Junjie, Li, Shaoqun, Wen, Lei, Peng, Zhangrui, Lai, Mingyao, Zhou, Cheng, Cai, Linbo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213218/ http://dx.doi.org/10.1093/noajnl/vdz014.088

Ejemplares similares

RADI-44. MANAGEMENT OF MULTIPLE BRAIN METASTASES BY STAGED SRS FOCUSING ON UTMOST RISK LESIONS
por: Zhen, Junjie, et al.
Publicado: (2019)

SDPS-23 CUMULATIVE TUMOR VOLUME THRESHOLD CORRELATES WITH NEUROCOGNITIVE IMPAIRMENT IN PATIENTS WITH NEWLY DIAGNOSED BRAIN METASTASES
por: Zhen, Junjie, et al.
Publicado: (2023)

OTHR-05. Diagnosis and Treatment of Solitary Pituitary Metastatic Cancer: A Case Series
por: Shan, Changguo, et al.
Publicado: (2021)

LPTO-07. CARCINOEMBRYONIC ANTIGEN OF CEREBROSPINAL FLUID PREDICT PROGNOSIS OF LEPTOMENINGEAL METASTASIS FROM NON-SMALL CELL LUNG CANCER
por: Zhen, Junjie, et al.
Publicado: (2019)

OTHR-06. ANALYSIS OF GENOMIC ALTERATIONS IN 154 BRAIN METASTASES
por: Ostorga, Antonio Dono, et al.
Publicado: (2019)

OTHR-04. INCIDENCE AND SURVIVAL OUTCOMES IN UROTHELIAL CARCINOMA BRAIN METASTASES
por: Kavouridis, Vasileios, et al.
Publicado: (2019)

OTHR-13. A DEEP LEARNING APPROACH TO DETECT CANCER METASTASES TO THE BRAIN IN MRI
por: Zhang, Min, et al.
Publicado: (2019)

RADI-07. Individualized Nomogram for Predicting Survival of Patients with Brain Metastases after Stereotactic Radiosurgery
por: Wen, Lei, et al.
Publicado: (2021)

OTHR-16. MOLECULAR PROFILING USING THE 92-GENE ASSAY FOR TUMOR CLASSIFICATION OF BRAIN METASTASES
por: Brenner, Andrew, et al.
Publicado: (2019)

OTHR-12. DRIVING RECOMMENDATIONS IN PATIENTS WITH NEWLY DIAGNOSED BREAST CANCER BRAIN METASTASES
por: Swartz, Leigh, et al.
Publicado: (2019)

OTHR-14. An immunogenomic analysis of melanoma brain metastases (MBM) compared to extracranial metastases (ECM)
por: Kennedy, Lucy Boyce, et al.
Publicado: (2021)

PATH-07. Diagnostic and therapeutic value of cerebrospinal fluid biopsy in pediatric brain tumors
por: Li, Shaoqun, et al.
Publicado: (2022)

OTHR-01. Unmet clinical needs in patients with brain metastases in the current treatment era
por: Eggen, Annemarie C, et al.
Publicado: (2021)

RADI-10. THERAPEUTIC EFFECTS OF fSRS IN 44 CASES OF BRAIN METASTASES OF NSCLC WITH A MAXIMUM DIAMETER ≥ 4CM AND ANALYSIS OF ITS PROGNOSTIC FACTORS
por: Mingyao, Lai, et al.
Publicado: (2019)

OTHR-10. THE NATIONAL DISTRIBUTION OF NEWLY-DIAGNOSED BRAIN METASTASES IN ADULTS VARIES WIDELY BY PATIENT DEMOGRAPHICS
por: Kavouridis, Vasileios, et al.
Publicado: (2019)

OTHR-01. USING COGNITION TO PREDICT RISK OF MEDICAL DECISION-MAKING IMPAIRMENT IN BRAIN CANCER
por: Gerstenecker, Adam, et al.
Publicado: (2019)

OTHR-12. The development of machine learning algorithms for the differentiation of glioma and brain metastases – a systematic review
por: Brim, Waverly Rose, et al.
Publicado: (2021)

OTHR-03. ENHANCEMENT OF T1W-GAD MRI IS ASSOCIATED WITH POST-SRS LOCAL CONTROL OF NSCLC BRAIN METASTASES
por: Milchenko, Mikhail, et al.
Publicado: (2019)

OTHR-15. PATIENTS WITH LIMITED STAGE SMALL CELL LUNG CANCER THAT RECUR WITH ISOLATED BRAIN METASTASES HAVE PROLONGED SURVIVAL
por: Bonder, Bryan, et al.
Publicado: (2019)

OTHR-03. Brain Metastasis Among Ovarian Cancer Patients
por: Limon, Dror, et al.
Publicado: (2021)

LGG-36. Analysis of BRAF-related mutations in pediatric low-grade glioma
por: Li, Shaoqun, et al.
Publicado: (2022)

OTHR-02. Engineered “of the shelf” allogeneic cellular therapies for metastatic brain tumors
por: Shah, Khalid, et al.
Publicado: (2021)

OTHR-07. ESTIMATING INCIDENCE PROPORTION OF BRAIN METASTASES AT DIAGNOSIS AND LIFETIME INCIDENCE AMONG CANCER PATIENTS DIAGNOSED FROM 2010–2015 IN CANADA
por: Paudel, Yuba Raj, et al.
Publicado: (2019)

OTHR-14. TREATMENT MONITORING OF IMMUNOTHERAPY AND TARGETED THERAPY USING FET PET IN PATIENTS WITH MELANOMA AND LUNG CANCER BRAIN METASTASES: INITIAL EXPERIENCES
por: Galldiks, Norbert, et al.
Publicado: (2019)

OTHR-09. IDENTIFYING EPIGENETIC SIGNATURES IN LUNG ADENOCARCINOMAS THAT PREDICT DEVELOPMENT OF BRAIN METASTASIS
por: Zuccato, Jeffrey, et al.
Publicado: (2019)

BSCI-09. Multiomic single cell analysis reveals emerging principles of tumor immune microenvironment inherent to NSCLC brain metastases
por: Wen, Lei, et al.
Publicado: (2021)

OTHR-10. Diverse survival outcomes of HER2+ Breast Cancer Brain Metastases (BrCBM) presenting with isolated brain relapse compared to those with concurrent extracranial disease
por: Noteware, Laura, et al.
Publicado: (2021)

OTHR-13. IMPACT the brain: improving metastatic breast cancer patient access to coordinated treatment
por: Grogan, Nicole, et al.
Publicado: (2021)

XRT-03. EFFICACY OF RE-IRRADIATION FOR PEDIATRIC DIFFUSE INTRINSIC PONTINE GLIOMAS
por: Cai, Linbo, et al.
Publicado: (2023)

Case Report: Clinicopathological and Genetic Features of IDH-Mutant Brainstem Glioma in Adults: Report of Five Cases
por: Zhou, Jiangfen, et al.
Publicado: (2022)

Efficacy and safety of osimertinib for leptomeningeal metastases from EGFR-mutant non-small cell lung cancer: a pooled analysis
por: Wen, Lei, et al.
Publicado: (2023)

LMD-06. A NSCLC patient with leptomeningeal metastasis harboring rare EGFR mutations G719S and L861Q benefited from doubling dosage of osimertinib: a case report
por: Wang, Hui, et al.
Publicado: (2021)

OTHR-17. PHYLOGENETIC RESOLUTION OF TISSUE-SPECIFIC METASTOGENIC CLONES IN RENAL CELL CARCINOMA
por: Moss, Nelson, et al.
Publicado: (2019)

Bone metastases in an adult patient with diffuse midline glioma: a case report
por: Li, Shaoqun, et al.
Publicado: (2020)

OTHR-11. Comprehensive Analysis of Driver Mutation Profile in a Cohort of Lung Cancer Patients Using Targeted Gene Panel Analysis with Focus on Brain Metastatic Disease
por: Kazarian, Marina, et al.
Publicado: (2021)

OTHR-38. The development of patient-derived models of pediatric brain tumors
por: Messiaen, Julie, et al.
Publicado: (2022)

Whole brain radiotherapy (WBRT) for leptomeningeal metastasis from NSCLC in the era of targeted therapy: a retrospective study
por: Zhen, Junjie, et al.
Publicado: (2020)

OTHR-05. THE ABILITY TO MAKE INFORMED TREATMENT DECISIONS IS COMPROMISED IN ADULTS WITH ADVANCED STAGE CANCER
por: Triebel, Kristen, et al.
Publicado: (2019)

OTHR-07. Systematic Review and Meta-analysis of Lung Cancer Brain Metastasis and Primary Tumor PD-L1 Expression Discordance
por: Tonse, Raees, et al.
Publicado: (2021)

OTHR-15. Assessment of TRIPOD adherence in articles developing machine learning models for differentiation of glioma from brain metastasis
por: Jekel, Leon, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_b6psh3k1e4pc6s02vvcn4c5u1f